Artica Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$12M
- Investors
-
5
Artica Therapeutics General Information
Description
Developer of novel therapies intended to treat severe autoimmune and inflammatory disorders. The company provides label-free cellular-based screening approaches to allow rapid progression of drug candidates, enabling healthcare professionals to have selective therapies for patients with unmet medical needs.
Contact Information
Website
www.artica-tx.comCorporate Office
- Biopartner 4
- Robert Boyleweg 4
- 2333 CG Leiden
- Netherlands
Corporate Office
- Biopartner 4
- Robert Boyleweg 4
- 2333 CG Leiden
- Netherlands
Artica Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 02-Nov-2023 | $12M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Jan-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Artica Therapeutics Comparisons
Industry
Financing
Details
Artica Therapeutics Competitors (2)
One of Artica Therapeutics’s 2 competitors is CV6 Therapeutics, a Venture Capital-Backed company based in Belfast, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CV6 Therapeutics | Venture Capital-Backed | Belfast, United Kingdom | ||||
| Numeric Biotech | Private Debt Financed | Rotterdam, Netherlands |
Artica Therapeutics Patents
Artica Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023031308-A1 | Ccr2 inhibitors | Inactive | 31-Aug-2021 |
Artica Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| InnovationQuarter | Venture Capital | Minority | ||
| Mibiton | Venture Capital | Minority | ||
| Seroba Life Sciences | Venture Capital | Minority | ||
| Thuja Capital Management | Venture Capital | Minority | ||
| BioGeneration Ventures | Venture Capital | Minority |
Artica Therapeutics FAQs
-
When was Artica Therapeutics founded?
Artica Therapeutics was founded in 2020.
-
Where is Artica Therapeutics headquartered?
Artica Therapeutics is headquartered in Leiden, Netherlands.
-
What industry is Artica Therapeutics in?
Artica Therapeutics’s primary industry is Drug Discovery.
-
Is Artica Therapeutics a private or public company?
Artica Therapeutics is a Private company.
-
What is Artica Therapeutics’s current revenue?
The current revenue for Artica Therapeutics is .
-
How much funding has Artica Therapeutics raised over time?
Artica Therapeutics has raised $12M.
-
Who are Artica Therapeutics’s investors?
InnovationQuarter, Mibiton, Seroba Life Sciences, Thuja Capital Management, and BioGeneration Ventures have invested in Artica Therapeutics.
-
Who are Artica Therapeutics’s competitors?
CV6 Therapeutics and Numeric Biotech are competitors of Artica Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process